Page last updated: 2024-10-31

metyrapone and EHS Tumor

metyrapone has been researched along with EHS Tumor in 2 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seifter, E2
Critselis, AN1
Levenson, SM2
Rettura, G2
Seifter, J1
Zisblatt, M1
Levine, N1

Other Studies

2 other studies available for metyrapone and EHS Tumor

ArticleYear
Effect of metyrapone and aminoglutethimide on the murine sarcoma (MuSV-M) and breast adenocarcinoma (C3HBA).
    Journal of surgical oncology, 1979, Volume: 12, Issue:3

    Topics: Adenocarcinoma; Aminoglutethimide; Animals; Female; Male; Mammary Neoplasms, Experimental; Metyrapon

1979
Metyrapone-inhibited oncogenesis in mice inoculated with a murine sarcoma virus.
    Journal of the National Cancer Institute, 1973, Volume: 51, Issue:6

    Topics: Animals; Diet; Metyrapone; Mice; Mice, Inbred Strains; Moloney murine leukemia virus; Organ Size; Sa

1973